英国非裔/加勒比裔男性前列腺癌主动监测的随访依从性与结局
该回顾性队列研究比较了英国一家高容量中心2005-2016年间458例低-中危前列腺癌主动监测患者中非裔/加勒比裔与其他族裔的随访依从性和临床结局。
要点
- 非裔/加勒比裔男性主动监测随访失约率显著高于其他族裔(24% vs 10%)。
- 非裔/加勒比裔疾病进展风险可能增加(HR 1.38),但未达统计学显著性(P=0.054)。
- 两族裔转为主动治疗的风险无差异(HR 1.03,95%CI 0.64-1.47)。
核心结论
- 英国非裔/加勒比裔前列腺癌主动监测患者随访依从性较差,需针对性服务。
- 非裔/加勒比裔转为治疗风险与其他族裔无差异,但疾病进展风险可能更高,需谨慎选择和监测。
研究设计与样本
- 回顾性队列研究,纳入2005-2016年英国一家高容量医院主动监测门诊中确诊低-中危前列腺癌且至少接受1次随访活检的458例男性。
主要发现
- 非裔/加勒比裔诊断时PSA中位数略低(5.0 vs 6.0 ng/mL),阳性穿刺针数中位数更多(2 vs 1)。
- 非裔/加勒比裔随访失约率显著更高(24% vs 10%,p<0.001)。
- 调整分析显示非裔/加勒比裔疾病进展风险HR 1.38(95%CI 0.99-1.91,P=0.054),升级风险HR 1.29(95%CI 0.87-1.92,P=0.305),均未达统计学显著性。
- 转为主动治疗的风险无族裔差异(HR 1.03,95%CI 0.64-1.47,P=0.873)。
关键数值与推荐
- 不依从定义为失约预约超过20%。
- 疾病进展怀疑定义为任何升级、阳性针数>30%、cT分期>3或PIRADS>3。
临床怎么用
- 对非裔/加勒比裔主动监测患者应加强随访提醒和依从性管理。
- 非裔/加勒比裔患者主动监测入选和监测方案需更审慎,警惕疾病进展风险。
局限性
- 回顾性单中心研究,样本量有限,结论需更大规模前瞻性多中心研究验证。
- 疾病进展风险未达统计学显著性,需更长随访确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Experiences of African/Afro-Caribbean men on active surveillance (AS) for prostate cancer (PCa) in the United Kingdom (UK) are not well documented. We compared follow-up appointments, adherence, and clinical outcomes among African/Afro-Caribbean men on AS at a high-volume UK hospital with other ethnicities. METHODS: Men with confirmed low-intermediate risk Pca who attended the AS clinic (2005-2016) and had undergone ≥1 follow-up biopsy (n = 458) were included. Non-adherence (defined as >20% missed appointments), suspicion of disease progression (any upgrading, >30% positive cores, cT-stage > 3, PIRADS > 3), any upgrading from diagnostic biopsy and conversion to active treatment (prostatectomy, radiotherapy or hormone therapy) according to ethnicity (African/Afro-Caribbean versus other ethnicities) were assessed using multivariable regression analysis. RESULTS: Twenty-three percent of eligible men were recorded as African/Afro-Caribbean, while the remainder were predominantly Caucasian. African/Afro-Caribbean men had slightly lower PSA at diagnosis (median 5.0 vs. 6.0 ng/mL) and more positive cores at diagnosis (median 2 vs. 1). They had a substantially higher rate of non-attendance at scheduled follow-up visits (24% vs. 10%, p < 0.001). Adjusted analyses suggest African/Afro-Caribbean men may be at increased risk of disease progression (hazard ratio [HR]: 1.38; 95% confidence interval [CI] 0.99-1.91, P = 0.054) and upgrading (HR: 1.29; 95% CI 0.87-1.92, P = 0.305), though neither reached statistical significance. No difference in risk of conversion to treatment was observed between ethnic groups (HR: 1.03; 95% CI 0.64-1.47, P = 0.873). CONCLUSIONS: African/Afro-Caribbean men on AS for PCa in the UK are less likely to adhere to scheduled appointments, suggesting a more tailored service addressing their specific needs may be required. While African/Afro-Caribbean men were no more likely to convert to treatment than Caucasian/other men, findings of a potentially higher risk of disease progression signal the need for careful selection and monitoring of African/Afro-Caribbean men on AS. Larger prospective, multicentre studies with longer follow-up are required to provide more definitive conclusions.
引用
- Kum F, Beckmann K, Aya H, et al. Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre. Prostate Cancer Prostatic Dis. 2021. PMID: 33558659. doi:10.1038/s41391-020-00313-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。